(Q34618917)

English

Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study

scientific article

Statements

Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study (English)
Nedjad Losic
Birgitte Biilmann Rønn
Henrik Frederiksen
James Wooldridge
Jørgen Petersen

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit